Author

Anagha Inguva

University of Colorado Anschutz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:gene regulatory network inference· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Craig T. JordaniD· 2 shared Angelo D’AlessandroiD· 1 shared Ben Kooiman· 1 shared Brett Stevens· 1 shared Courtney L. JonesiD· 1 shared Dallas Jones· 1 shared Daniel StephensoniD· 1 shared Dejene Tufa· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Craig T. JordanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Metabolic vulnerabilities in Down syndrome B-cell acute lymphoblastic leukemia can be targeted using Venetoclax

Dallas Jones, Elena Woods, Zhenhua Li, Kristin L. Schaller, Eric Hoffmeyer, Ben Kooiman, Joseph Fernandez, Tegan Wharton, Dejene Tufa, Spencer C. Hall, George Trahan, Kelly W. Maloney, Holly Pacenta, Kelly Sullivan, Joaquin Espinosa, , Michael R. Verneris

This study identifies metabolic vulnerabilities in Down syndrome B-cell acute lymphoblastic leukemia and shows that Venetoclax effectively targets these vulnerabilities.

Haematologica · Oct 22, 2026Peer-reviewedCancer Biology

siRNA Mediated Genetic Perturbation of Primary Human Leukemia Stem and Progenitor Cells

Anagha Inguva, Hunter Tolison, Jeremy Rahkola, Craig T. Jordan, Courtney L. Jones, Maria L. Amaya

This study develops an efficient siRNA transfection method for primary human leukemia stem and progenitor cells, enabling effective gene knockdown and biological activity assessment.

bioRxiv · Sep 17, 2025 · PreprintCancer Biology